ARROWHEAD PHARMACEUTICALS, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2010 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $1.7M, unchanged year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $1.7M, unchanged from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $1.7M, unchanged from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $1.7M, unchanged from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.7M $500K $0 0% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-26
Q2 2024 $1.7M $400K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.7M $400K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.7M $400K $0 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $1.7M $500K $0 0% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-26
Q2 2023 $1.7M $400K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.7M $400K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.7M $400K $0 0% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q3 2022 $1.7M $500K $0 0% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-26
Q2 2022 $1.7M $400K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.7M $400K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $1.7M $400K $0 0% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q3 2021 $1.7M $500K $0 0% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-29
Q2 2021 $1.7M $400K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.7M $400K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.7M $400K $0 0% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 $1.7M $500K +$75.3K +17.7% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 $1.62M $400K -$25.1K -5.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.65M $400K -$25.1K -5.91% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.67M $400K -$25.1K -5.91% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $1.7M $425K -$430 -0.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-22
Q2 2019 $1.7M $425K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.7M $425K +$1.00 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.7M $425K $0 0% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q3 2018 $1.7M $425K $0 0% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 $1.7M $425K $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $1.7M $425K $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.7M $425K $0 0% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $1.7M $425K $0 0% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-25
Q2 2017 $1.7M $425K $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.7M $425K $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.7M $425K -$13.9K -3.16% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $1.71M $425K -$13.7K -3.11% Jul 1, 2016 Sep 30, 2016 10-K 2018-12-11
Q2 2016 $1.73M $425K -$13.7K -3.11% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $1.74M $425K +$270K +174% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.47M $439K +$425K +3113% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 $1.05M $439K +$425K +3111% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-12
Q2 2015 $621K $439K +$425K +3111% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $196K $155K +$142K +1037% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $54.7K $13.7K $0 0% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $54.7K $13.7K Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 $13.7K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $13.7K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $13.7K -$60.5K -81.6% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q4 2012 $74.1K +$2.5K +3.49% Oct 1, 2012 Dec 31, 2012 10-Q 2013-02-13
Q4 2011 $71.6K +$11.2K +18.5% Oct 1, 2011 Dec 31, 2011 10-Q 2012-02-09
Q2 2011 $60.5K $0 0% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $60.5K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 $60.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.